Park Jong-Gil, Xu Xu, Cho Sungyun, Lee Ann-Hwee
From the Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY.
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1772-81. doi: 10.1161/ATVBAHA.116.307790. Epub 2016 Jul 14.
Liver-enriched transcription factor cAMP-responsive element-binding protein H (CREBH) regulates plasma triglyceride clearance by inducing lipoprotein lipase cofactors, such as apolipoprotein A-IV (apoA-IV), apoA-V, and apoC-II. CREBH also regulates apoA-I transcription. This study aims to determine whether CREBH has a role in lipoprotein metabolism and development of atherosclerosis.
CREBH-deficient Creb3l3(-/-) mice were bred with Ldlr(-/-) mice creating Ldlr(-/-) Creb3l3(-/-) double knockout mice. Mice were fed on a high-fat and high-sucrose Western diet for 20 weeks. We showed that CREBH deletion in Ldlr(-/-) mice increased very low-density lipoprotein-associated triglyceride and cholesterol levels, consistent with the impairment of lipoprotein lipase-mediated triglyceride clearance in these mice. In contrast, high-density lipoprotein cholesterol levels were decreased in CREBH-deficient mice, which was associated with decreased production of apoA-I from the liver. The results indicate that CREBH directly activated Apoa1 gene transcription. Accompanied by the worsened atherogenic lipid profile, Ldlr(-/-) Creb3l3(-/-) mice developed significantly more atherosclerotic lesions in the aortas than Ldlr(-/-) mice.
We identified CREBH as an important regulator of lipoprotein metabolism and suggest that increasing hepatic CREBH activity may be a novel strategy for prevention and treatment of atherosclerosis.
肝脏富集转录因子环磷酸腺苷反应元件结合蛋白H(CREBH)通过诱导脂蛋白脂肪酶辅助因子,如载脂蛋白A-IV(apoA-IV)、载脂蛋白A-V和载脂蛋白C-II,来调节血浆甘油三酯清除。CREBH还调节载脂蛋白A-I的转录。本研究旨在确定CREBH在脂蛋白代谢和动脉粥样硬化发展中是否起作用。
将CREBH缺陷的Creb3l3基因敲除小鼠(Creb3l3-/-)与低密度脂蛋白受体基因敲除小鼠(Ldlr-/-)杂交,培育出Ldlr-/- Creb3l3-/-双敲除小鼠。给小鼠喂食高脂高糖的西式饮食20周。我们发现,Ldlr-/-小鼠中CREBH的缺失会增加极低密度脂蛋白相关的甘油三酯和胆固醇水平,这与这些小鼠中脂蛋白脂肪酶介导的甘油三酯清除受损一致。相反,CREBH缺陷小鼠的高密度脂蛋白胆固醇水平降低,这与肝脏中载脂蛋白A-I的产生减少有关。结果表明,CREBH直接激活Apoa1基因转录。伴随着致动脉粥样硬化脂质谱的恶化,Ldlr-/- Creb3l3-/-小鼠主动脉中的动脉粥样硬化病变比Ldlr-/-小鼠明显更多。
我们确定CREBH是脂蛋白代谢的重要调节因子,并表明增加肝脏CREBH活性可能是预防和治疗动脉粥样硬化的新策略。